Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 27, 2025
Event: Regulation FD Disclosure regarding the posting of an Investor Presentation to the company website.
Key Financial Metrics
This filing does not contain specific financial data. The document serves solely to disclose the availability of an attached Investor Presentation (Exhibit 99.1). Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not provided in this text.
Material Changes
No material changes to financial performance or operations are reported within the text of this filing. The filing references an external presentation for current business updates.
Guidance, Outlook, and Risks
- Management Commentary: The Company posted an Investor Presentation current as of March 27, 2025.
- Forward-Looking Statements: The Company explicitly disclaims any obligation to correct or update the material in the Investor Presentation in the future.
- Legal Status of Information: The information in the attached presentation is furnished and not deemed "filed" under Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Investor Presentation) for specific financial figures and strategic updates.
- Verify the date of the presentation (March 27, 2025) to ensure data currency.
- Note that the Company has no obligation to update the information contained in the presentation.
- Confirm that the presentation is not legally "filed" for liability purposes under Section 18 of the Exchange Act.